Seattle Genetics

Seattle Genetics: The Busy Season Is Set to Begin
Seeking Alpha
Fri, 08/6/10 - 07:58 am
Seattle Genetics
3 Development-Stage Drugmakers Worth Watching
Motley Fool
Sun, 08/1/10 - 02:29 pm
InterMune
Medivation
Exelixis
Bristol-Myers Squibb
GSK
Roche
Seattle Genetics
Regeneron
10 Firms Expecting Clinical Trial Results
TheStreet.com
Wed, 07/14/10 - 10:53 am
clinical trials
Ariad Pharmaceuticals
AstraZeneca
Biomarin
Bristol-Myers Squibb
Cyclacel
Corcept Therapeutics
Merck
ONYX Pharmaceuticals
Raptor Pharmaceuticals
Seattle Genetics
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Time For Gilead To Open Its Wallet
Investopedia
Tue, 07/6/10 - 09:06 am
Gilead Sciences
Alexion
Human Genome Sciences
Seattle Genetics
Genzyme
Incyte
Targacept
M&A
Pharmasset
Seattle Genetics' Dark Horse Drug Candidate
Motley Fool
Tue, 06/22/10 - 12:30 pm
Seattle Genetics
cancer
lintuzumab
acute myeloid leukemia
Seattle Genetics Leads the Way in Next Generation Antibody Technologies
Seeking Alpha
Tue, 06/1/10 - 05:53 am
Seattle Genetics
monoclonal antibodies
Immunogen
Teva Pharmaceuticals
Roche
Seattle Genetics Inc. Q1 2010 Earnings Call Transcript
Seeking Alpha
Sun, 05/2/10 - 10:45 am
earnings
Seattle Genetics
Seattle Genetics reports Q1 net income of $11.5M
Bizjournals.com
Tue, 04/27/10 - 09:35 pm
Seattle Genetics
earnings
Seattle Genetics, Takeda & Millennium begin phase-III Aethera trial of brentuximab vedotin for post-transplant Hodgkin lymphoma
Pharmabiz
Sat, 04/10/10 - 12:45 pm
Seattle Genetics
Takeda
brentuximab vedotin
Hodgkin's lymphoma
Seattle Genetics 4Q loss narrows on higher revenue
Yahoo/AP
Tue, 02/9/10 - 06:28 pm
Seattle Genetics
earnings
Pharma’s Holiday Shopping Spree
CNBC
Mon, 12/21/09 - 04:17 pm
M&A
Sanofi
Chattem
Teva Pharmaceuticals
OncoGenex
GSK
Seattle Genetics
Incyte
Pfizer
Eli Lilly
Athersys
Seattle Genetics signs development deal with Glaxo
Yahoo/AP
Mon, 12/21/09 - 11:44 am
GSK
Seattle Genetics
antibodies
liscensing
Seattle Genetics Gets Boost from Cancer Drug Deal with Takeda
Seeking Alpha
Sun, 12/20/09 - 10:43 am
Seattle Genetics
Takeda
Hodgkin's lymphoma
Millennium strikes $365M deal for Seattle Genetics' cancer antibody
Fierce Biotech
Tue, 12/15/09 - 09:25 am
Seattle Genetics
Millennium
antibodies
cancer
Genentech sheds pact as pipeline review claims another deal
Fierce Biotech
Fri, 12/11/09 - 10:31 am
pipelines
Genentech
Roche
Seattle Genetics
partnerships
Buyout Buzz at ASH Hematology Confab
Seeking Alpha
Mon, 12/7/09 - 07:44 pm
M&A
Allos
Celgene
Cyclacel
Seattle Genetics
13 Biotechs to Watch for at Hematology Conference
Seeking Alpha
Mon, 11/30/09 - 09:32 am
hematology
Allos
ONYX Pharmaceuticals
Facet Biotech
Seattle Genetics
Gentium
Immunogen
Cyclacel
Sunesis
Trubion
Pharmacyclics
Keryx
Aeterna Zentaris
Ariad Pharmaceuticals
Seattle Genetics, Amicus plunge; AVI, DepoMed rally
Marketwatch
Mon, 10/5/09 - 03:04 pm
Seattle Genetics
Amicus Therapeutics
AVI BioPharma
biotech
Seattle Genetics Halts Lymphoma Drug Study
TheStreet.com
Mon, 10/5/09 - 10:52 am
Seattle Genetics
lymphoma
drug studies
dacetuzumab
non-Hodgkin's lymphoma

Pages